Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which
exhibit some symptom similarities and are thus considered to share a common etiology. The …

Migraine is a neurovascular disorder that can be debilitating for individuals and society.
Current research focuses on finding effective analgesics and management strategies for …

Background Clinical trials and real-world studies revealed a spectrum of response to CGRP
(-receptor) monoclonal antibodies (mAbs) in migraine prophylaxis, ranging from no effect at …

In recent years, numerous efforts have been made to identify reliable biomarkers useful in
migraine diagnosis and progression or associated with the response to a specific treatment …

Migraine is a common primary headache disorder, affecting about 14% of the population.
Importantly, it was indicated as the second cause of disability globally and the leading cause …

Cannabidiol (CBD) is the main pharmacologically active phytocannabinoid. CBD exerts an
analgesic effect in several pain models, does not have side effects and has low toxicity. The …

A bidirectional causal relationship has been established between temporomandibular
disorders (TMDs) and chronic headaches. Recent advances in the neurobiology of chronic …

Migraine is a complex and multi-system dysfunction. The realization of its pathophysiology
and diagnosis is developing rapidly. Migraine has been linked to gastrointestinal disorders …

Background The upper cervical dorsal root ganglia (DRG) are important for the transmission
of sensory information associated with the back of the head and neck, contributing to head …

Migraine, a debilitating neurological condition, significantly affects patients' quality of life.
Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist approved …